We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Chunghwa Telecom
CHT
$33.2B
| $1.27M | ﹤0.01% |
34,313
+2,813
| +9% | +$104K |
|
952
Advanced Micro Devices
AMD
$851B
| $1.26M | ﹤0.01% |
27,540
+1,768
| +7% | +$65.1K |
|
953
Ziff Davis
ZD
$1.9B
| $1.26M | ﹤0.01% |
15,502
+355
| +2% | +$29.3K |
|
|
PS
954
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $1.26M | ﹤0.01% |
73,288
+5,270
| +8% | +$89.7K |
|
955
Liberty Media Series C
FWONK
$24.3B
| $1.26M | ﹤0.01% |
28,362
-968
| -3% | -$40.3K |
|
956
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $1.26M | ﹤0.01% |
49,655
| – | – |
|
957
Invesco Biotechnology & Genome ETF
PBE
$281M
| $1.25M | ﹤0.01% |
22,465
| – | – |
|
958
Bright Horizons
BFAM
$3.99B
| $1.25M | ﹤0.01% |
8,321
+2,540
| +44% | +$381K |
|
|
SF
959
Stifel
SF
$12.3B
| $1.25M | ﹤0.01% |
46,282
-3,425
| -7% | -$89.5K |
|
|
HRC
960
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.25M | ﹤0.01% |
10,997
+369
| +3% | +$38.9K |
|
961
EastGroup Properties
EGP
$11.5B
| $1.24M | ﹤0.01% |
9,361
-64
| -0.7% | -$8.41K |
|
962
National Grid
NGG
$82.7B
| $1.24M | ﹤0.01% |
22,321
+2,300
| +11% | +$118K |
|
963
NVE Corp
NVEC
$569M
| $1.24M | ﹤0.01% |
17,306
-6,905
| -29% | -$450K |
|
964
Flowers Foods
FLO
$1.64B
| $1.23M | ﹤0.01% |
56,750
-12,086
| -18% | -$263K |
|
965
Cabot Corp
CBT
$4.65B
| $1.23M | ﹤0.01% |
25,954
+80
| +0.3% | +$3.71K |
|
966
NetApp
NTAP
$32.9B
| $1.23M | ﹤0.01% |
19,742
-5,012
| -20% | -$292K |
|
|
IBKC
967
DELISTED
IBERIABANK Corp
IBKC
| $1.23M | ﹤0.01% |
16,410
-1,069
| -6% | -$79.4K |
|
|
PACW
968
DELISTED
PacWest Bancorp
PACW
| $1.23M | ﹤0.01% |
32,011
+3,683
| +13% | +$139K |
|
|
GWPH
969
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.22M | ﹤0.01% |
11,710
-82
| -0.7% | -$9.2K |
|
970
Entergy
ETR
$54.1B
| $1.22M | ﹤0.01% |
20,376
-3,472
| -15% | -$205K |
|
|
FMBI
971
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.22M | ﹤0.01% |
52,940
-3,171
| -6% | -$67.5K |
|
972
Lyft
LYFT
$5.39B
| $1.22M | ﹤0.01% |
28,309
+4,992
| +21% | +$219K |
|
973
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.58B
| $1.22M | ﹤0.01% |
41,473
+523
| +1% | +$15K |
|
974
HealthEquity
HQY
$7.91B
| $1.21M | ﹤0.01% |
16,375
-220
| -1% | -$13.7K |
|
975
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $1.21M | ﹤0.01% |
13,274
+5,267
| +66% | +$480K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.